Novotech, an Asia-Pacific-based CRO, has acquired Australasian specialist CRO Clinical Network Services (CNS) as part of a mission in hopes to expand services to biopharma for early phase product development and clinical research through to later phase regional and global trials.
Read the full release here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.